Gilead Sciences Sinks 11% After Lung Cancer Study FailsA numerical improvement in OS favoring SG was observed in the study ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE